Biological Chemistry · 2015 · 17 citations · 18 references
Life SciencesBiochemistryCell BiologyCell ProliferationCell SignalingSignal TransductionCell MigrationLipid SignalingProtein Kinase CascadesRenal DiseaseMek InhibitionMek InhibitorsPhosphatidylinositol 3-Kinase-akt SignalingPi3k SignalingPi3k-akt Signaling PathwaySphingolipid SignalingSphingosine 1-Phosphate SignalingSphingosine-1-phosphate Signaling
Both of the sphingosine kinase (SK) subtypes SK-1 and SK-2 catalyze the production of the bioactive lipid molecule sphingosine 1-phosphate (S1P). However, the subtype-specific cellular functions are largely unknown. In this study, we investigated the cellular function of SK-2 in primary mouse renal mesangial cells (mMC) and embryonic fibroblasts (MEF) from wild-type C57BL/6 or SK-2 knockout (SK2ko) mice. We found that SK2ko cells displayed a significantly higher proliferative and migratory activity when compared to wild-type cells, with concomitant increased cellular activities of the classical extracellular signal regulated kinase (ERK) and PI3K/Akt cascades, and of the small G protein RhoA. Furthermore, we detected an upregulation of SK-1 protein and S1P3 receptor mRNA expression in SK-2ko cells. The MEK inhibitor U0126 and the S1P1/3 receptor antagonist VPC23019 blocked the increased migration of SK-2ko cells. Additionally, S1P3ko mesangial cells showed a reduced proliferative behavior and reduced migration rate upon S1P stimulation, suggesting a crucial involvement of the S1P3 receptor. In summary, our data demonstrate that SK-2 exerts suppressive effects on cell growth and migration in renal mesangial cells and fibroblasts, and that therapeutic targeting of SKs for treating proliferative diseases requires subtype-selective inhibitors.
18
Spatiotemporal dynamics of RhoA activity in migrating cells
Olivier Pertz, Louis Hodgson, Richard Klemke et al. · Nature · 2006 · 826 citations
Matthias P. Wymann, Ginette Bulgarelli-Leva, Marketa Zvelebil et al. · Molecular and Cellular Biology · 1996 · 680 citations · Full text
Discovery and evaluation of inhibitors of human sphingosine kinase.
Kevin J. French, Randy S. Schrecengost, Brian D. Lee et al. · PubMed · 2003 · 600 citations
Medicine, Oncology, Pharmacology +10